BOT 4.17% 34.5¢ botanix pharmaceuticals ltd

Bot Chart, page-464

  1. 800 Posts.
    lightbulb Created with Sketch. 383
    can I ask why anyone else feels the results have been delayed? I have my own theories, curious to hear others. not necessarily a negative given the pharma sector.

    I don't enjoy ARGO selling, but I feel it's simply to derisk their portfolio given the natural volatility of the clinical trial results.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.